Table 2. IC50 of the CDKs inhibitors employed in this study
IC50
CDK1CDK2CDK5CDK9
Ro 3306a20 nM
K03861b15.4 nM
Roscovitinec0.7 μM0.16 μM
LDC000067d5.5 μM2.4 μM44 nM
  • a Vassilev LT, et al Proc Natl Acad Sci USA 2006, 103(28), 10660–10665.

  • b Alexander LT, et al ACS Chem Biol 2015, 10(9), 2116–2125.

  • c Meijer L, et al Eur J Biochem 1997, 243(1‐2), 527–536.

  • d Albert TK, et al Br J Pharmacol 2014, 171(1), 55–68.